We help biotech companies across the entire value chain—from early-stage ventures securing initial funding to established companies expanding into international markets—unlock growth, accelerate innovation, and improve operational and commercial outcomes.

NDB Holding Group supports clients in navigating scientific, regulatory, and commercial complexities while scaling capabilities, optimizing resources, and capturing value from emerging technologies. Our approach combines strategic insight, operational expertise, and data-driven analysis to drive measurable impact for biotech organizations.

Our Biotech Practice works with start-ups, mid-size companies, and large global biotech firms, helping them advance product pipelines, attract investment, and expand market presence. With experience across research, development, and commercialization, we help clients overcome scientific and business challenges to achieve sustainable growth.

Our areas of expertise include:

• Early-stage strategy and funding: Supporting venture creation, investment strategy, and capital raising to accelerate growth and attract strategic partners.

• Portfolio and pipeline management: Optimizing R&D priorities, resource allocation, and risk-adjusted investment decisions.

• Regulatory strategy: Navigating complex regulatory requirements across multiple markets to expedite product approval and market entry.

• Commercialization and market access: Designing launch strategies, pricing, and reimbursement pathways to maximize product uptake and revenue.

• Operational excellence: Improving lab, production, and organizational processes to enhance efficiency, reduce costs, and scale operations effectively.

Recent example of our work:
We helped an emerging biotech company scale its operations globally by designing an end-to-end commercialization strategy, optimizing R&D resource allocation, and developing a market access plan for multiple regions. The client successfully secured Series B funding, accelerated product development timelines by 18%, and established a framework for international market entry.